CCDBF(CCDBF)
CCDBF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $8.42B | $8.81B | $9.19B |
| Low | $8.25B | $8.46B | $8.91B |
| High | $8.50B | $8.92B | $9.29B |
| EBITDA Avg | $1.92B | $2.01B | $2.09B |
| Low | $1.88B | $1.93B | $2.03B |
| High | $1.94B | $2.03B | $2.11B |
| EBIT Avg | $1.39B | $1.45B | $1.51B |
| Low | $1.36B | $1.39B | $1.47B |
| High | $1.40B | $1.47B | $1.53B |
| Net Income Avg | $921M | $989M | $1.10B |
| Low | $885M | $950M | $1.06B |
| High | $935M | $1.00B | $1.12B |
| EPS Avg | $5.24 | $5.63 | $6.27 |
| Low | $5.04 | $5.41 | $6.02 |
| High | $5.32 | $5.71 | $6.36 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.18B | $2.08B | $2.15B | $2.29B | $2.26B | $2.17B |
| Low | $2.09B | $1.99B | $2.06B | $2.19B | $2.17B | $2.08B |
| High | $2.23B | $2.12B | $2.19B | $2.33B | $2.31B | $2.22B |
| EBITDA Avg | $495M | $473M | $489M | $520M | $515M | $495M |
| Low | $475M | $453M | $469M | $499M | $494M | $475M |
| High | $507M | $482M | $499M | $531M | $526M | $506M |
| EBIT Avg | $359M | $343M | $354M | $377M | $373M | $358M |
| Low | $344M | $328M | $340M | $361M | $357M | $344M |
| High | $367M | $349M | $362M | $385M | $381M | $366M |
| Net Income Avg | $234M | $215M | $233M | $253M | $249M | $227M |
| Low | $222M | $204M | $221M | $240M | $235M | $215M |
| High | $241M | $221M | $240M | $260M | $255M | $234M |
| EPS Avg | $1.37 | $1.26 | $1.37 | $1.48 | $1.45 | $1.33 |
| Low | $1.30 | $1.19 | $1.29 | $1.40 | $1.38 | $1.26 |
| High | $1.41 | $1.29 | $1.40 | $1.52 | $1.50 | $1.37 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 7 / 1 | 4 / 1 | 4 / 1 | 7 / 1 |